High IL-6 and SARS-CoV-2 RNAaemia may reflect pathophysiologic evidence of future deterioration of COVID-19, including hyperinflammation and viral overload, thereby helping us to decide therapeutic strategy. The gene discussed is IL6; the disease is COVID-19.